stumbling block

Why aren't more TB patients getting the new life-saving drug? Geography is one reason

Only 30 patients in India have been given the new drug Bedaquiline in the last three months.

Sexagenarian Shekhar Verma* lives in Faridabad, Haryana which is part of National Capital Region. A general store owner, he has developed resistance to many crucial antibiotics while being treated for tuberculosis for the last couple of years. The doctor at the National Institute of Tuberculosis & Respiratory Diseases told Verma that the only antibiotic that has high success for patients like him is Bedaquiline. But he cannot get Bedaquiline under the Revised National Tuberculosis Control Programme, government’s tuberculosis control programme.

To get the drug under the RNTCP, Verma will need to show that he lives in Delhi, one of five cities in which the government is providing the drug. He does not have proof of address in Delhi. He approached a private hospital for Bedaquiline but since the medicine is not available in retail shops, no doctor will prescribe the drug.

Verma's work at his store sustained his family of four for many years. Owing to his unstable health, he stopped going to the store, which is wife now manages. The elder of his two sons works in a security firm.

Akruti Kumar’s* father too has developed extreme drug resistant tuberculosis, often abbreviated as XDR-TB, with a first line of antiobiotic treatment failing him and now relying on second-line treatment. The RNTCP cannot treat him with Bedaquiline since he is a resident of NOIDA and not Delhi.

Location, location, location

Bedaquiline was rolled out under the conditional access programme of the RNTCP in which six hospitals in five Indian cities were chosen to provide the drug under World Health Organisation guidelines. Patients needed to belong to either Delhi, Mumbai, Chennai, Ahmedabad or Guwahati. The government has received doses for 300 patients in donation from the United States Agency for International Development which administers civilan aid from the US to other countries. Three hundred more treatment doses will be donated next year.

Sunil Khaparde, head of Central TB Division of the health ministry said that geographical criterion is important to follow up with patients. “Bedaquiline is administered for six months and follow-up of patients continue for six more months," he said. "Thus, we have to be careful about patients’ proximity to the hospitals.”

“It is a new antibiotic and we need to use it judiciously,"said Delhi State TB officer Ashwani Khanna. "We do not want antibiotic resistance to develop against this medicine.”

Khanna added that superior laboratory facilities are needed to determine which patients can be given the medicine. “Very few hospitals can meet all the requirements – trained doctors and staff, laboratory with all facilities and other facilities in case of an adverse effect.”

He said that the government was being extra cautious with Bedaquiline since it had not undergone a third phase of clinical trials, which are normally large scale trials on human subjects. The USFDA had exempted Bedaquiline from third phase clinical trials on the grounds on exceptional results from the first two rounds of trials and to make the drug available to the public as soon as possible.

Moving too cautiously?

The activist speaking on condition of anonymity said that providing access to treatment is not as difficult as it is made out to be. Patients can even be monitored long-distance with new technological tools. "The main thing to be monitored while administering Bedaquiline is patient’s heart because it disturbs function of heart," he said. "Any patient who is close to ECG testing machine for electrocardiogram, can be given the medicine and monitored from long distance.”

Rational use of antibiotics does not necessitate restricting use. “A robust programme can ensure that there is no misuse of antibiotics and still all needy patients get it," said an activist on condition of anonymity. "To stop misuse, it should not be sold in open market or in private treatments. But it cannot be restricted in a government programme.”

The rigid regime has meant that only about 30 patients have been started on Bedaquiline in RNTCP in the past three months. There is fear that the available doses will go waste if the government does not ramp up its utilisation.

“Delhi has 10 patients and there is a similar number is in Mumbai," said an official who did not want to be identified. "The other cities have 4 or 5 patients each. We can treat 300 patients and the doses expire in October next year.”

Compassionate use

India’s progress is “pathetic” and “glacially slow” in providing such crucial medicine to its ailing population, said Dr Zarir F Udwadia, consultant physician and tuberculosis specialist at Hinduja Hospital in Mumbai. Udwadia is currently treating 25 patients with Bedaquiline citing compassionate use.

“This is almost half of all patients being treated in India,” he remarked. On the grounds of compassionate use, a drug manufacturer gives a medicine free-of-cost to patients if their doctor has convincing evidence that the patients will die without the medicine. Janssen Pharmaceuticals, an arm of Johnson and Johnson, is the drug-maker giving out Bedaquiline. The company has also provided the doses that USAID has donated to the Indian government.

Getting the drug on grounds of compassionate use, however, is not easy. The doctor need to fill in numerous forms based in each of the patient's test results and few practitioners are willing to spend the time. Even when the medicine is arranged through compassionate use, the cost of diagnostics borne by the patient can run into tens of thousands or rupees.

India has 71,000 multi-drug resistant tuberculosis patients. According to a World Health Organisation report, nearly 10% of all multi-drug resistant TB patients have extensively drug resistant TB or XDR-TB, for whom both the first and second lines of antibiotic treatment have failed. Thus, India is estimated to have more than 7,000 XDR-TB patients.

Bedaquiline is administered to pre-XDR-TB patients. These are patients with resistance to isoniazid and rifampicin used to treat MDR-TB and either a fluoroquinolone or a second-line injectable agent, but not both.

The rates of prevalence of XDR-TB are not uniform everywhere, doctors say. “In Delhi nearly 22% of all MDR cases are XDR and pre-XDR. In Mumbai, it is nearly 60%,” said Khanna. Taking this into account, there would be a much higher number of patients needing Bedaquiline.

“It is good that government launched the much needed drug but they are moving too slow," said Chapal Mehra, a TB activist in New Delhi. "We do not know on what basis was the figure of 300 and 600 was arrived at. The government has to estimate both in the public and private sectors who need the medicine and work towards achieving that target.”

Mehra said that the government should work with the private sector to start patients on Bedaquiline.

“There are multiple-barriers to the medicine right now," he pointed out. "Why should a patient from Jharkhand be not eligible for it? Patients from private sector also do not have access to it (through the RNTCP). The programme is structured to privilege a few.”

Learning from South Africa

“India is one of the high burden countries for DR-TB," said Jennifer J Furin, lecturer on Global Health and Social Medicine at Harvard Medical School. "A lot more patients have to be given Bedaquiline soon. The government should use the drug carefully because we cannot waste it to resistance, but the progress is too slow.”

India is lagging behind South Africa, which, through its robust TB programme, has put a large number of patients on Bedaquiline.

“South Africa launched the drug in July 2015," said Furin. "Within three months they had 200 patients on Bedaquiline. As we speak, the country is giving the medicine to 3,000 patients, which is a huge progress.”

India, on the other hand, will not be able to give Bedaquiline to more than 600 patients for the next two years. And this will only create bigger hurdles to fighting TB. Furin said the understanding is that the donors will see India’s progress with regard to the first 300 treatment doses. If this is not satisfactory, then the further donation will face impediments.

*Names changed

We welcome your comments at letters@scroll.in.
Sponsored Content BY 

How sustainable farming practices can secure India's food for the future

India is home to 15% of the world’s undernourished population.

Food security is a pressing problem in India and in the world. According to the Food and Agriculture Organization of the UN (FAO), it is estimated that over 190 million people go hungry every day in the country.

Evidence for India’s food challenge can be found in the fact that the yield per hectare of rice, one of India’s principal crops, is 2177 kgs per hectare, lagging behind countries such as China and Brazil that have yield rates of 4263 kgs/hectare and 3265 kgs/hectare respectively. The cereal yield per hectare in the country is also 2,981 kgs per hectare, lagging far behind countries such as China, Japan and the US.

The slow growth of agricultural production in India can be attributed to an inefficient rural transport system, lack of awareness about the treatment of crops, limited access to modern farming technology and the shrinking agricultural land due to urbanization. Add to that, an irregular monsoon and the fact that 63% of agricultural land is dependent on rainfall further increase the difficulties we face.

Despite these odds, there is huge potential for India to increase its agricultural productivity to meet the food requirements of its growing population.

The good news is that experience in India and other countries shows that the adoption of sustainable farming practices can increase both productivity and reduce ecological harm.

Sustainable agriculture techniques enable higher resource efficiency – they help produce greater agricultural output while using lesser land, water and energy, ensuring profitability for the farmer. These essentially include methods that, among other things, protect and enhance the crops and the soil, improve water absorption and use efficient seed treatments. While Indian farmers have traditionally followed these principles, new technology now makes them more effective.

For example, for soil enhancement, certified biodegradable mulch films are now available. A mulch film is a layer of protective material applied to soil to conserve moisture and fertility. Most mulch films used in agriculture today are made of polyethylene (PE), which has the unwanted overhead of disposal. It is a labour intensive and time-consuming process to remove the PE mulch film after usage. If not done, it affects soil quality and hence, crop yield. An independently certified biodegradable mulch film, on the other hand, is directly absorbed by the microorganisms in the soil. It conserves the soil properties, eliminates soil contamination, and saves the labor cost that comes with PE mulch films.

The other perpetual challenge for India’s farms is the availability of water. Many food crops like rice and sugarcane have a high-water requirement. In a country like India, where majority of the agricultural land is rain-fed, low rainfall years can wreak havoc for crops and cause a slew of other problems - a surge in crop prices and a reduction in access to essential food items. Again, Indian farmers have long experience in water conservation that can now be enhanced through technology.

Seeds can now be treated with enhancements that help them improve their root systems. This leads to more efficient water absorption.

In addition to soil and water management, the third big factor, better seed treatment, can also significantly improve crop health and boost productivity. These solutions include application of fungicides and insecticides that protect the seed from unwanted fungi and parasites that can damage crops or hinder growth, and increase productivity.

While sustainable agriculture through soil, water and seed management can increase crop yields, an efficient warehousing and distribution system is also necessary to ensure that the output reaches the consumers. According to a study by CIPHET, Indian government’s harvest-research body, up to 67 million tons of food get wasted every year — a quantity equivalent to that consumed by the entire state of Bihar in a year. Perishables, such as fruits and vegetables, end up rotting in store houses or during transportation due to pests, erratic weather and the lack of modern storage facilities. In fact, simply bringing down food wastage and increasing the efficiency in distribution alone can significantly help improve food security. Innovations such as special tarpaulins, that keep perishables cool during transit, and more efficient insulation solutions can reduce rotting and reduce energy usage in cold storage.

Thus, all three aspects — production, storage, and distribution — need to be optimized if India is to feed its ever-growing population.

One company working to drive increased sustainability down the entire agriculture value chain is BASF. For example, the company offers cutting edge seed treatments that protect crops from disease and provide plant health benefits such as enhanced vitality and better tolerance for stress and cold. In addition, BASF has developed a biodegradable mulch film from its ecovio® bioplastic that is certified compostable – meaning farmers can reap the benefits of better soil without risk of contamination or increased labor costs. These and more of the company’s innovations are helping farmers in India achieve higher and more sustainable yields.

Of course, products are only one part of the solution. The company also recognizes the importance of training farmers in sustainable farming practices and in the safe use of its products. To this end, BASF engaged in a widespread farmer outreach program called Samruddhi from 2007 to 2014. Their ‘Suraksha Hamesha’ (safety always) program reached over 23,000 farmers and 4,000 spray men across India in 2016 alone. In addition to training, the company also offers a ‘Sanrakshan® Kit’ to farmers that includes personal protection tools and equipment. All these efforts serve to spread awareness about the sustainable and responsible use of crop protection products – ensuring that farmers stay safe while producing good quality food.

Interested in learning more about BASF’s work in sustainable agriculture? See here.

This article was produced by the Scroll marketing team on behalf of BASF and not by the Scroll editorial team.